Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201102442 Principal Investigator: Wagner-Johnston, Nina
Title: An Open Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin Administered in Combo with Rituxan compared to defined MD's Choice Therapy in Subjects with Relapsed/Refractory CD22 Positive Aggressive NHL Who are not candidates for Intensive High Dose Chemotherapy
Phase: III Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to determine whether inotuzumab ozogamicin in combination with rituximab is safe and effective when compared with 2 other therapies which are used to treat patients with this condition.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)